title: Structural biology of presenilin 1 complexes.
abstract: The presenilin genes were first identified as the site of missense mutations causing early onset autosomal dominant familial Alzheimer's disease. Subsequent work has shown that the presenilin proteins are the catalytic subunits of a hetero-tetrameric complex containing APH1, nicastrin and PEN-2. This complex (variously termed presenilin complex or gamma-secretase complex) performs an unusual type of proteolysis in which the transmembrane domains of Type I proteins are cleaved within the hydrophobic compartment of the membrane. This review describes some of the molecular and structural biology of this unusual enzyme complex. The presenilin complex is a bilobed structure. The head domain contains the ectodomain of nicastrin. The base domain contains a central cavity with a lateral cleft that likely provides the route for access of the substrate to the catalytic cavity within the centre of the base domain. There are reciprocal allosteric interactions between various sites in the complex that affect its function. For instance, binding of Compound E, a peptidomimetic inhibitor to the PS1 N-terminus, induces significant conformational changes that reduces substrate binding at the initial substrate docking site, and thus inhibits substrate cleavage. However, there is a reciprocal allosteric interaction between these sites such that prior binding of the substrate to the initial docking site paradoxically increases the binding of the Compound E peptidomimetic inhibitor. Such reciprocal interactions are likely to form the basis of a gating mechanism that underlies access of substrate to the catalytic site. An increasingly detailed understanding of the structural biology of the presenilin complex is an essential step towards rational design of substrate- and/or cleavage site-specific modulators of presenilin complex function.
authors.forename: Yi
authors.initials: Y
authors.lastname: Li
authors.forename: Christopher
authors.initials: C
authors.lastname: Bohm
authors.forename: Roger
authors.initials: R
authors.lastname: Dodd
authors.forename: Fusheng
authors.initials: F
authors.lastname: Chen
authors.forename: Seema
authors.initials: S
authors.lastname: Qamar
authors.forename: Gerold
authors.initials: G
authors.lastname: Schmitt-Ulms
authors.forename: Paul E
authors.initials: PE
authors.lastname: Fraser
authors.affiliation: Cambridge Institute for Medical Research, Wellcome Trust MRC Building, Addenbrookes Hospital, Hills Road, Cambridge CB2 0XY, UK. p.hyslop@utoronto.ca.
authors.forename: Peter H
authors.initials: PH
authors.lastname: St George-Hyslop
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism*; D053829:Amyloid Precursor Protein Secretases / Q000378:metabolism*; D000818:Animals; D002462:Cell Membrane / Q000378:metabolism*; D006801:Humans; D062105:Molecular Docking Simulation / Q000379:methods; D053764:Presenilin-1 / Q000737:chemistry / Q000378:metabolism*; D011485:Protein Binding; D059748:Proteolysis
chemical_list: D053764:Presenilin-1; D053829:Amyloid Precursor Protein Secretases